well its a deal, page-50

Well put, as usual, abdm.

Im even more impressed today by the accumulation methods.
Yesterday I mentioned that accumulation by a single large order is rather inviting selling than it does buying since wide spread momentum is missing.
Today's action further supports my notion that accumulation is ongoing. Sell orders are often placed strategically with the least possible amount of shares to help make the sell side appear overly active.

The efficiency of this accumulation, the success in avoiding day traders taking over this stock today manifests my beliefs that we have a serious investor collecting OBJ shares in the moment.



The FMCG deal is now openly in the making, our speculation can rest now, the deal is on its way. So much seems obvious.
The fact that we have received a LOI which was executed today, implying that this letter was sent to OBJ by the FMCG ( quite amuzing to assume that OBJ sends a letter of intent to the FMCG and hopes for the best, as some here speculate ).

The LOI from the FMCG states that our technology will be applied "accross multiple categories".
This to me implies the multi billion dollar drug delivery
which was initiated in 08, as well as the "ordered" FIM technology, which now to me seems obviously ordered by the FMCG.
I had suspected in the last days that the FMCG was in fact the company driving a deal forward and it seems to be unfolding now.

We have now reached the level of "technical evaluations" within our testing cycle with the FCMG, which to me indicates that testing of efficiency of our technogly has ended and we are now within evaluation progresses of how to implement the technology within a range of products and pipelines according to the particular needs of the partner company ( the progress of technical evaluations usually commence in the last stages of testing cycles, the ongoing consumer acceptance testing for instance ).
This is a very remarkable next step for everybody following OBJ over the years and indeed a milestone, as mentioned in the ann.

The word exclusivity has me particularly excited, beside the obvious 5 year outlook or longer for royalties, depending of life time of patent.

Personally, I expect a deal very similar to Altea for their Passport Patch, everybody familiar with the industry can deduct where I see our revenues and share price in the not so distant future.


The most interesting part currently is for me to observe how trading activity will prevent ST traders entering.

I stated in my post 3 days ago that trading had dramatically changed since the ann a month ago. I see a clear continuation of OBJ maturing away from day trader influence towards an investor stock.